CIK 0001472012
- Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770694340
- Phone
- +1 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $334,224
- in 1 filing, $334K under 10b5-1 plans
Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 56 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-23 | Rosett Max Chief Financial Officer | Grant or award | +47,250 | 101,287 | ||
| 2026-07-23 | Rosett Max Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +94,500 | 94,500 | ||
| 2026-06-15 | Rosett Max Chief Financial Officer | Option exercise 10b5-1 | +60,000 | $1.05 | $63K | 114,037 |
| 2026-06-15 | Rosett Max Chief Financial Officer | Sale 10b5-1 | −60,000 | $18.23 | $1.1M | 54,037 |
| 2026-06-15 | Rosett Max Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −60,000 | 0 | ||
| 2026-04-02 | Rosett Max Chief Financial Officer | Option exercise 10b5-1 | +31,848 | $1.05 | $33K | 79,324 |
| 2026-04-02 | Rosett Max Chief Financial Officer | Option exercise 10b5-1 | +39,713 | $1.35 | $54K | 119,037 |
| 2026-04-02 | Rosett Max Chief Financial Officer | Sale 10b5-1 | −63,656 | $21.91 | $1.4M | 55,381 |
| 2026-04-02 | Rosett Max Chief Financial Officer | Sale 10b5-1 | −1,344 | $22.48 | $30K | 54,037 |
| 2026-04-02 | Rosett Max Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −31,848 | 60,000 | ||
| 2026-04-02 | Rosett Max Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −39,713 | 0 | ||
| 2025-07-29 | Rosett Max Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +207,000 | 207,000 | ||
| 2024-09-19 | Rosett Max Chief Financial Officer | Option exercise | +42,000 | $1.05 | $44K | 61,856 |
| 2024-09-19 | Rosett Max Chief Financial Officer | Sale | −14,380 | $16.01 | $230K | 47,476 |
| 2024-09-19 | Rosett Max Chief Financial Officer | Option exercise · Stock option (right to buy) | −42,000 | 91,848 | ||
| 2024-08-09 | Rosett Max EVP, Operations & CFO | Grant or award · Stock option (right to buy) | +190,000 | 190,000 | ||
| 2024-05-16 | Rosett Max EVP, Operations & CFO | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2024-01-31 | Rosett Max EVP, OPERATIONS & INTERIM CFO | Grant or award · Stock option (right to buy) | +175,000 | 175,000 |
Page 1 of 1 · 18 trades